The country of origin of Estradiol Vaginal Cream USP, 0.01% in dosage form
Issued May 22, 2026 by U.S. Customs and Border Protection.
Tariff classification
Product description
01% in dosage form.Estradiol Vaginal Creamisestradiol hemihydratean estrogen hormone a medicinal preparation containing , , indicated for the treatment of moderate to severe symptoms of vulvar andas the active ingredient. It isvaginal atrophy due to menopause.
CBP rationale
substantial transformation analysis is applicable. See, e.g.,Headquarters Ruling Letter (“HQ”) H301619, dated November 6, 2018. The test for determining whether asubstantial transformation will occur is whether an article emerges from a process with a new name,character, or use different from that possessed by the article prior to processing. See Texas Instruments Inc. v.United States, 681 F.2d 778 (C.C.P.A. 1982). This determination is based on the totality of the evidence. See National Hand Tool Corp. v. United States, 16 C.I.T. 308 (1992), aff’d, 989 F.2d 1201 (Fed. Cir. 1993).In this case, we find the mixing of the active ingredient estradiol hemihydrate made in the Netherlands with()the inactive ingredients into the final Estradiol Cream in dosage form in India does not resultVaginal 0.01%in a substantial transformation and the country of origin will be eNetherlands.th You also submitted pictures of labels for our review. Based upon the labels provided, the subject productdoes not appear to be legally marked with the proper country of origin.
Full text
N361554May 22, 2026OT:RR:NC:N3:138
CATEGORY: OriginKamesh VenugopalEncube Ethicals, Inc.200 Meredith DriveDurham, NC 27713RE: The country of origin of Estradiol Vaginal Cream USP, 0.01% in dosage formDear Mr. Venugopal:In your letter dated
May 15, 2026
, you requested a country of origin ruling on Estradiol Vaginal Cream USP,0.01% in dosage form.Estradiol Vaginal Creamisestradiol hemihydratean estrogen hormone a medicinal preparation containing , , indicated for the treatment of moderate to severe symptoms of vulvar andas the active ingredient. It isvaginal atrophy due to menopause.You stated that the active pharmaceutical ingredient (API),estradiol hemihydrate, is manufactured in the Netherlands and that the finished cream in dosage form is made in India. In India, estradiol hemihydrate willbe mixed with various inactive ingredients to produce the final Estradiol Cream in dosage form.Vaginal When determining the country of origin, the substantial transformation analysis is applicable. See, e.g.,Headquarters Ruling Letter (“HQ”) H301619, dated November 6, 2018. The test for determining whether asubstantial transformation will occur is whether an article emerges from a process with a new name,character, or use different from that possessed by the article prior to processing. See Texas Instruments Inc. v.United States, 681 F.2d 778 (C.C.P.A. 1982). This determination is based on the totality of the evidence. See National Hand Tool Corp. v. United States, 16 C.I.T. 308 (1992), aff’d, 989 F.2d 1201 (Fed. Cir. 1993).In this case, we find the mixing of the active ingredient estradiol hemihydrate made in the Netherlands with()the inactive ingredients into the final Estradiol Cream in dosage form in India does not resultVaginal 0.01%in a substantial transformation and the country of origin will be eNetherlands.th You also submitted pictures of labels for our review. Based upon the labels provided, the subject productdoes not appear to be legally marked with the proper country of origin. The labels state the product ismanufactured in India However, the country of origin is the etherland where the API is made and should.Nsbe marked “Made in”, Product of,” or other words of similar meaning with “Netherlands” as the country of“origin.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public HealthSecurity and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which areadministered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, andCosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or byvisiting their website at www.fda.gov.The holding set forth above applies only to the specific factual situation and merchandise description asidentified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations(CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of theinformation furnished in the ruling letter, whether directly, by reference, or by implication, is accurate andcomplete in every material respect. In the event that the facts are modified in any way, or if the goods do notconform to these facts at time of importation, you should bring this to the attention of U.S. Customs andBorder Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2.Additionally, we note that the material facts described in the foregoing ruling may be subject to periodicverification by CBP.This ruling is being issued under the provisions of Part 177 of the Customs and Border ProtectionRegulations (19 C.F.R. 177).A copy of the ruling or the control number indicated above should be provided with the entry documentsfiled at the time this merchandise is imported. If you have any questions regarding the ruling, please contactNational Import Specialist Judy Lee at [email protected].
Sincerely,
(for)James P. ForkanDirectorNational Commodity Specialist Division
Ruling history
More rulings on the same tariff codes
Appraisement of Zircon from Australia; Computed Value Method
Dear Ms. Sugama This is in response to your October 9, 2025, request for a binding ruling, on PB” or “importer”) regarding the proper behalf of Kumho P&B Chemicals, Inc. (“K method of appraisement for prospective entries of bagged and bulk epoxy resins manufactured in South Korea. The importer has asked that certain information submitted in connection with this ruling be treated as confidential. Inasmuch as this request conforms to the 9 C.F.R. § 177.2(b)(7), the request for confidentiality is approved. The requirements of 1 information contained within brackets in this ruling or in the attachments to the ruling request, forwarded to our office, will not be released to the public and will be withheld from published version of this ruling. FACTS KPB is a non-resident importer and manufacturer that will be importing bulk and bagged epoxy resins into the United States. KPB produces five types of epoxy resins in liquid epoxy resins; (2) solid epoxy resins; (3) solution epoxy resins; South
Country of origin and marking of plastic and aluminum components from China to be assembled in the United States
The country of origin of Weber liquid propane and natural gas grills from Thailand
The country of origin of a marking crayon
The country of origin of vibratory rollers
The country of origin of battery charger for power tools
The country of origin of Candesartan Cilexetil and Hydrochlorothiazide Tablets USP, in dosage form
The country of origin of a thermistor
The country of origin of gas griddles from Thailand
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →